ShockWave Medical, Inc.
SWAV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $11,950 | $7,037 | $7,326 | $10,464 |
| - Cash | $282 | $328 | $498 | $141 |
| + Debt | $777 | $771 | $765 | $59 |
| Enterprise Value | $12,445 | $7,480 | $7,593 | $10,382 |
| Revenue | $219 | $203 | $186 | $180 |
| % Growth | 7.8% | 9.1% | 3.2% | – |
| Gross Profit | $191 | $178 | $162 | $156 |
| % Margin | 87.1% | 87.5% | 86.8% | 86.4% |
| EBITDA | $56 | $61 | $51 | $36 |
| % Margin | 25.6% | 30.3% | 27.2% | 20.2% |
| Net Income | $55 | $44 | $35 | $29 |
| % Margin | 25.3% | 21.8% | 18.8% | 16% |
| EPS Diluted | 1.44 | 1.16 | 0.92 | 0.76 |
| % Growth | 24.1% | 26.1% | 21.1% | – |
| Operating Cash Flow | $36 | $72 | $51 | $40 |
| Capital Expenditures | -$8 | -$8 | -$7 | -$9 |
| Free Cash Flow | $27 | $64 | $44 | $31 |